Blueweave
Middle East Molecular Diagnostics Market

Middle East Molecular Diagnostics Market

Middle East Molecular Diagnostics Market - By Product (Systems, Kits & Consumables, Software & Other Products); By Testing Location (Laboratory Testing, Point-of-Care Testing); By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (IHC), Other Technologies); By Application (Core Molecular Diagnostics, Reproductive Genetics, Companion Diagnostics (CDx), Liquid Biopsy, Other Applications); By End User (Hospitals, Diagnostic Centers, Out-Patient Clinics/General Practitioners, Research Laboratories, Other End Users); By Country (Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar, Rest of Middle East), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

  • Published Date: March 2023
  • Report ID: BWC23250
  • Available Format: PDF
  • Page: 240

Report Overview

An increasing focus on diagnosing and treating rising number of infectious disease and cancer affected patients and growing awareness and acceptance of personalized medicines in the region are expected to boost the growth of the Middle East molecular diagnostics market during the forecast period between 2023 and 2029.

Middle East Molecular Diagnostics Market - Industry Trends & Forecast Report, 2029

Middle East molecular diagnostics market size was estimated to be worth USD 527.82 million in 2022. During the forecast period between 2023 and 2029, the Middle East molecular diagnostics market size is projected to grow at a CAGR of 8.3% reaching a value of USD 919.34 million by 2029. Major growth factors for the Middle East molecular diagnostics market include aging population, rising communicable and non-communicable illness prevalence, improvements in molecular diagnostics technology, and increasing expenditures on healthcare.

Middle East Molecular Diagnostics Market

Middle East Molecular Diagnostics Market – Overview

The growing healthcare industry makes use of technology to diagnose and monitor complex conditions, detect risk, and, most importantly, select the most tailored treatments and therapies for individual patients. molecular diagnostics is the study of how individuals express their genes as proteins and the application of medical and microbiological technology in medical imaging science to examine biological markers residing in the proteome and genome. For decades, molecular diagnostics has been regarded as a superior tool for reaching the goal of faster disease diagnosis with fewer complications. The demand for these procedures is growing, especially for diagnosing infectious diseases.

Middle East Molecular Diagnostics Market

Growth Drivers

Increasing Number of Infectious Disease-related Clinical Trials

With the rising burden of communicable diseases, the number of clinical trials in Middle Eastern countries has also spiked. According to the data published by the Clinical Trials Arena, “the Middle East has seen an 888% increase in the number of infectious disease trials taking place over the past decade, the largest increase for any region worldwide.” The data also revealed that Iran hosted the highest number of trials in the area in 2020, accounting for 79.3% of all trials. With 9.1% and 3.4%, respectively, of the region's trials taking place, Israel and Saudi Arabia came in second and third.

Restraints

High Cost of Molecular Diagnostics

Molecular approaches typically cost more than more common conventional approaches. Some labs might find the expense of supplies and equipment to be prohibitive. Furthermore, certain clinical laboratories might not have the specific area needed for molecular amplification techniques. Additionally, the market growth is severely constrained by inadequate reimbursements. Obtaining private health insurance to cover diagnostic testing is a challenge for the majority of diagnostic firms.

Impact of COVID-19 on Middle East Molecular Diagnostics Market

The development of the molecular diagnostics market was aided by the improved usage of molecular diagnostic technologies for COVID-19 testing. In the Middle East, treating infectious illnesses has risen to the top of the medical priority list as a result of the COVID-19 pandemic. The demand for RT-PCR registered a sharp spike post the pandemic outbreak. According to a report published by the National Institutes of Health, “molecular diagnostic assays are a major group of tests used to diagnose COVID-19.” Reverse transcription polymerase chain reaction (RT-PCR) is now the most used technique for detecting SARS-CoV-2 RNA.

Middle East Molecular Diagnostics Market

Segmental Coverage

Middle East Molecular Diagnostics Market – By Product

Based on product, the Middle East molecular diagnostics market is segregated into systems, kits & consumables, software, and other product segments. The kits and consumables segment holds the highest market share. A full polymerase chain reaction (PCR) typically needs five basic reagents, including a DNA template, forward and reverse primers, DNA polymerase, deoxynucleotide triphosphates (dNTPs), and reaction buffer. Standard reagents aid in obtaining reliable and timely results. It is envisaged that standardized outcomes, increased efficacy, and cost-effectiveness will encourage market expansion.

Middle East Molecular Diagnostics Market – By Testing Location

Based on testing location, the Middle East molecular diagnostics market is segmented into laboratory testing and point-of-care testing. Laboratory testing accounts for the highest share in the Middle East molecular diagnostics market. Lab tests have historically been utilized in hospitals and diagnostic facilities and are widely acknowledged. Another significant factor projected to drive the market is a growth in the number of efforts done by the government to provide various services, such as reimbursement for diagnostic tests.

Middle East Molecular Diagnostics Market Size

Middle East Molecular Diagnostics Market – By Technology

Based on technology, the Middle East molecular diagnostics market is segmented into polymerase chain reaction (PCR), next-generation sequencing, isothermal nucleic acid amplification technology (INAAT), microarray, in-situ hybridization (ISH), immunohistochemistry (IHC), and other technologies. The polymerase chain reaction (PCR) technology accounts for the largest market share. While a COVID-19 infection is still in its early stages, fast antigen testing frequently results in false negatives and false positives. In contrast, PCR assays are far less likely to have similar problems. Its higher accuracy compared to its counterparts play a crucial factor in propelling its market growth.

Middle East Molecular Diagnostics Market – By Application

Based on application, the Middle East molecular diagnostics market is segmented into core molecular diagnostics, reproductive genetics, companion diagnostics (CDX), liquid biopsy, and other applications. The core molecular diagnostics segment holds the highest share in the Middle East molecular diagnostics market. The increased use of molecular testing in laboratories to treat illnesses is primarily responsible for this market segment's expansion. The majority of the Middle East's molecular diagnostics market is serviced by a wide number of inclusive core molecular diagnostics applications.

Middle East Molecular Diagnostics Market – By End Users

Based on end users, the Middle East molecular diagnostics market is segmented into hospitals, diagnostic centers, outpatient clinics/general practitioners, research laboratories, and other end users. The hospital segment accounts for the highest market share. The increasing number of patients approaching hospitals for regular checkups and in case of suffering from communicable diseases contributes to the growing demand for molecular diagnostics tools in hospitals. Hospitals also offer real-time assistance from health professionals as well as quick commencement of treatments which is contributing to its market growth.

Middle East Molecular Diagnostics Market – By Country

The Middle East molecular diagnostics market covers the following major countries: Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar and the rest of Middle East. Saudi Arabia dominates the Middle East molecular diagnostics market owing to the increasing prevalence of communicable diseases in this region. To stop the spread of infectious illnesses including seasonal flu, tuberculosis (TB), yellow fever, and others that are becoming more common in Saudi Arabia, the government is setting up diagnostic facilities. Eventually, this led to a notable increase in the molecular diagnostics market in the area.

Competitive Landscape

Major competitors in the Middle East molecular diagnostics market include Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In September 2022 OpGen, Inc., a US-based molecular microbiology solutions company, announced that its subsidiary Curetis GmbH signed a distribution agreement for the distribution of Unyvero systems in Qatar and the UAE with Leader Life Sciences through their trading firm Leader Medical Supplies Trading LLC, a member of the Leader Healthcare Group.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

Saudi Arabia, UAE, Lebanon, Bahrain, Oman, Qatar, Rest of Middle East

Product/ Service Segmentation

Product, Testing Location, Technology, Application, End User, Country

Key Players

Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc.

 

 

By Product

  • Systems

  • Kits & Consumables

  • Software

  • Other Products

By Testing Location

  • Laboratory Testing

  • Point-of-Care Testing

By Technology

  • Polymerase Chain Reaction (PCR)

  • Next-Generation Sequencing

  • Isothermal Nucleic Acid Amplification Technology (INAAT)

  • Microarray

  • In-Situ Hybridization (ISH)

  • Immunohistochemistry (IHC)

  • Other Technologies

By Application

  • Core Molecular Diagnostics

  • Reproductive Genetics

  • Companion Diagnostics (CDx)

  • Liquid Biopsy

  • Other Applications

By End User

  • Hospitals

  • Diagnostic Centres

  • Out-Patient Clinics/General Practitioners

  • Research Laboratories

  • Other End Users

By Country

  • Saudi Arabia

  • UAE

  • Lebanon

  • Bahrain

  • Oman

  • Qatar

  • Rest of Middle East

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Middle East Molecular Diagnostics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing Prevalence of Infectious Diseases and Various Types of Cancer in the Middle East
        2. Increase in Awareness and Acceptance of Personalized Medicines in the Middle East
        3. Significant External Funding for Executing Research and Development Exercises
      2. Restraints
        1. Uncertain Reimbursement Scenario
        2. Lack of High-Complexity Testing Centres in the Middle East
      3. Opportunities
        1. Massive Scope for Adoption of Molecular Diagnostics
        2. Rise of Next-Generation Ultrasensitive Molecular Diagnostics
        3. Novel Revenue Streams
      4. Challenges
        1. COVID-19 Impact on Middle East Molecular Diagnostics
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Middle East Molecular Diagnostics Market Overview
    1. Market Size & Forecast by Value, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
        1. Systems
        2. Kits & Consumables
        3. Software
        4. Other Product
      2. By Testing Location
        1. Laboratory Testing
        2. Point-of-Care Testing
      3. By Technology
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Microarray
        5. In-Situ Hybridization (ISH)
        6. Immunohistochemistry (IHC)
        7. Other Technologies
      4. By Application
        1. Core Molecular Diagnostics
        2. Reproductive Genetics
        3. Companion Diagnostics (CDx)
        4. Liquid Biopsy
        5. Other Applications
      5. By End User
        1. Hospitals
        2. Diagnostic Centres
        3. Out-Patient Clinics/General Practitioners
        4. Research Laboratories
        5. Other End Users
      6. By Country
        1. Saudi Arabia
        2. UAE
        3. Lebanon
        4. Bahrain
        5. Oman
        6. Qatar
        7. Rest of Middle East
  5. Saudi Arabia Molecular Diagnostics Market
      1. Market Size & Forecast by Value, 2019–2 029
      2. By Value (USD Million)
    1. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  6. UAE Molecular Diagnostics Market
      1. Market Size & Forecast by Value, 2019–2 029
      2. By Value (USD Million)
    1. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  7. Lebanon Molecular Diagnostics Market
    1. Market Size & Forecast by Value, 2019–2 029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  8. Bahrain Molecular Diagnostics Market
    1. Market Size & Forecast by Value, 2019–2 029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  9. Oman Molecular Diagnostics Market
    1. Market Size & Forecast by Value, 2019–2 029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  10. Qatar Molecular Diagnostics Market
    1. Market Size & Forecast by Value, 2019–2 029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  11. Rest of Middle East Molecular Diagnostics Market
    1. Market Size & Forecast by Value, 2019–2 029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Product
      2. By Testing Location
      3. By Technology
      4. By Application
      5. By End Users
  12. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Middle East Molecular Diagnostics Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Mergers, Acquisitions, Partnerships, and others)
  13. Impact of Covid-19 on Middle East Molecular Diagnostics Market
  14. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Abbott
    2. Agilent Technologies, Inc.
    3. bioMerieux SA
    4. Babirus Medical Equipment LLC
    5. Bio-Rad Laboratories, Inc.
    6. Danaher
    7. F. Hoffmann-La Roche Ltd.
    8. Guardant Health
    9. Illumina, Inc.
    10. QIAGEN N.V.
    11. Thermo Fisher Scientific Inc
    12. Other prominent players.
  15. Key Strategic Recommendations
  16. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation

 

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List of Figures

Figure 1   Middle East Molecular Diagnostics Market Segmentation

Figure 2   Middle East Molecular Diagnostics Market Value Chain Analysis

Figure 3   Company Market Share Analysis, 2022

Figure 4   Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 5   Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 6   Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 7   Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 8   Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 9   Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 10 Middle East Molecular Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 11 Saudi Arabia Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 12 Saudi Arabia Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 13 Saudi Arabia Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 14 Saudi Arabia Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 15 Saudi Arabia Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 16 Saudi Arabia Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 17 UAE Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 18 UAE Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 19 UAE Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 20 UAE Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 21 UAE Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 22 UAE Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 23 Lebanon Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 24 Lebanon Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 25 Lebanon Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 26 Lebanon Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 27 Lebanon Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 28 Lebanon Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 29 Bahrain Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 30 Bahrain Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 31 Bahrain Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 32 Bahrain Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 33 Bahrain Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 34 Bahrain Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 35 Oman Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 36 Oman Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 37 Oman Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 38 Oman Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 39 Oman Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 40 Oman Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 41 Qatar Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 42 Qatar Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 43 Qatar Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 44 Qatar Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45 Qatar Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 46 Qatar Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 47 Rest of Middle East Molecular Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 48 Rest of Middle East Molecular Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 49 Rest of Middle East Molecular Diagnostics Market Share, By Testing Location, By Value, 2019–2029

Figure 50 Rest of Middle East Molecular Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 51 Rest of Middle East Molecular Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 52 Rest of Middle East Molecular Diagnostics Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1     Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 2     Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 3     Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4     Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 5     Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 6     Middle East Molecular Diagnostics Market Size, By Country, By Value, 2019–2029

Table 7     Saudi Arabia Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 8     Saudi Arabia Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 9     Saudi Arabia Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 10   Saudi Arabia Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 11   Saudi Arabia Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 12   UAE Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 13   UAE Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 14   UAE Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 15   UAE Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 16   UAE Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 17   Lebanon Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 18   Lebanon Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 19   Lebanon Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 20   Lebanon Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 21   Lebanon Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 22   Bahrain Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 23   Bahrain Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 24   Bahrain Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 25   Bahrain Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 26   Bahrain Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 27   Oman Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 28   Oman Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 29   Oman Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 30   Oman Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 31   Oman Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 32   Qatar Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 33   Qatar Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 34   Qatar Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 35   Qatar Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 36   Qatar Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 37   Rest of Middle East Molecular Diagnostics Market Size, By Product, By Value, 2019–2029

Table 38   Rest of Middle East Molecular Diagnostics Market Size, By Testing Location, By Value, 2019–2029

Table 39   Rest of Middle East Molecular Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 40   Rest of Middle East Molecular Diagnostics Market Size, By Application, By Value, 2019–2029

Table 41   Rest of Middle East Molecular Diagnostics Market Size, By End User, By Value, 2019–2029

Table 42   Abbott Company Overview

Table 43   Abbott Financial Overview

Table 44   Agilent Technologies, Inc. Company Overview

Table 45   Agilent Technologies, Inc. Financial Overview

Table 46   bioMerieux SA Company Overview

Table 47   bioMerieux SA Financial Overview

Table 48   Babirus Medical Equipment LLC Company Overview

Table 49   Babirus Medical Equipment LLC Financial Overview

Table 50   Bio-Rad Laboratories, Inc. Company Overview

Table 51   Bio-Rad Laboratories, Inc. Financial Overview

Table 52   Danaher Company Overview

Table 53   Danaher Financial Overview

Table 54   F. Hoffmann-La Roche Ltd. Company Overview

Table 55   F. Hoffmann-La Roche Ltd. Financial Overview

Table 56   Guardant Health Company Overview

Table 57   Guardant Health Financial Overview

Table 58   Illumina, Inc. Company Overview

Table 59   Illumina, Inc. Financial Overview

Table 60   QIAGEN N.V. Company Overview

Table 61   QIAGEN N.V. Financial Overview

Table 62   Thermo Fisher Scientific Inc Company Overview

Table 63   Thermo Fisher Scientific Inc Financial Overview

 

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Middle East Molecular Diagnostics Market size was estimated at USD 527.82 million in 2022.
Ans: Major factors driving the growth of Middle East Molecular Diagnostics Market include increase in awareness and acceptance of personalized medicines in the middle east and significant external funding for executing research and development exercises.
Ans: The hospitals segment held the highest market share in the Middle East Molecular Diagnostics Market by end user.
Ans: Saudi Arabia is expected to grow at the fastest rate in Middle East Molecular Diagnostics Market during the forecast period between 2023 and 2029.
Ans: Key players in Middle East Molecular Diagnostics Market include Abbott, Agilent Technologies, Inc., bioMerieux SA, Babirus Medical Equipment LLC, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Guardant Health, Illumina, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc.